Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
Conservative activist Robby Starbuck settles defamation lawsuit against Meta, to collaborate with them on reducing bias and misinformation in AI models.
Colts QB Richardson's injury raises durability concerns as analysts criticize his decision-making.
Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
Conservative activist Robby Starbuck settles defamation lawsuit against Meta, to collaborate with them on reducing bias and misinformation in AI models.
Colts QB Richardson's injury raises durability concerns as analysts criticize his decision-making.